194 related articles for article (PubMed ID: 10799816)
41. A Systematic Approach of Employing Quality by Design Principles: Risk Assessment and Design of Experiments to Demonstrate Process Understanding and Identify the Critical Process Parameters for Coating of the Ethylcellulose Pseudolatex Dispersion Using Non-Conventional Fluid Bed Process.
Kothari BH; Fahmy R; Claycamp HG; Moore CMV; Chatterjee S; Hoag SW
AAPS PharmSciTech; 2017 May; 18(4):1135-1157. PubMed ID: 27417225
[TBL] [Abstract][Full Text] [Related]
42. Dry powder coating of pellets with micronized Eudragit RS for extended drug release.
Pearnchob N; Bodmeier R
Pharm Res; 2003 Dec; 20(12):1970-6. PubMed ID: 14725361
[TBL] [Abstract][Full Text] [Related]
43. Preparation of codeine-resinate and chlorpheniramine-resinate sustained-release suspension and its pharmacokinetic evaluation in beagle dogs.
Zeng HX; Cheng G; Pan WS; Zhong GP; Huang M
Drug Dev Ind Pharm; 2007 Jun; 33(6):649-65. PubMed ID: 17613029
[TBL] [Abstract][Full Text] [Related]
44. The influence of drug type on the release profiles from Surelease-coated pellets.
Sadeghi F; Ford JL; Rajabi-Siahboomi A
Int J Pharm; 2003 Mar; 254(2):123-35. PubMed ID: 12623188
[TBL] [Abstract][Full Text] [Related]
45. An investigation into the mechanical and transport properties of aqueous latex films: a new hypothesis for the film-forming mechanism of aqueous dispersion system.
Guo JH; Robertson RE; Amidon GL
Pharm Res; 1993 Mar; 10(3):405-10. PubMed ID: 8464814
[TBL] [Abstract][Full Text] [Related]
46. Production of spherical pellets by a hot-melt extrusion and spheronization process.
Young CR; Koleng JJ; McGinity JW
Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
[TBL] [Abstract][Full Text] [Related]
47. Improvement of the low-temperature stability of an aqueous colloidal ethylcellulose dispersion, Aquacoat ECD, and preparation/characterization of a redispersible Aquacoat ECD powder.
Wagner K; Bodmeier R
Drug Dev Ind Pharm; 2003 Mar; 29(3):267-75. PubMed ID: 12741608
[TBL] [Abstract][Full Text] [Related]
48. Aqueous HPMCAS coatings: effects of formulation and processing parameters on drug release and mass transport mechanisms.
Siepmann F; Siepmann J; Walther M; MacRae R; Bodmeier R
Eur J Pharm Biopharm; 2006 Jul; 63(3):262-9. PubMed ID: 16621484
[TBL] [Abstract][Full Text] [Related]
49. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
Sauer D; McGinity J
Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
[TBL] [Abstract][Full Text] [Related]
50. Eudragit NE40-drug mixed coating system for controlling drug release of core pellets.
Rahman NU; Yuen KH
Drug Dev Ind Pharm; 2005 May; 31(4-5):339-47. PubMed ID: 16093199
[TBL] [Abstract][Full Text] [Related]
51. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
[TBL] [Abstract][Full Text] [Related]
52. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the drug release patterns and long term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers.
Kranz H; Gutsche S
Int J Pharm; 2009 Oct; 380(1-2):112-9. PubMed ID: 19632313
[TBL] [Abstract][Full Text] [Related]
54. Influence of the drying technique on theophylline pellets prepared by extrusion-spheronization.
Pérez J; Rabisková M
Int J Pharm; 2002 Aug; 242(1-2):349-51. PubMed ID: 12176277
[TBL] [Abstract][Full Text] [Related]
55. The effect of ethylcellulose molecular weight on the properties of theophylline microspheres.
Dashevsky A; Zessin G
J Microencapsul; 1997; 14(3):273-80. PubMed ID: 9147278
[TBL] [Abstract][Full Text] [Related]
56. Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads.
Fan C; Pai-Thakur R; Phuapradit W; Zhang L; Tian H; Malick W; Shah N; Kislalioglu MS
Eur J Pharm Sci; 2009 Apr; 37(1):1-10. PubMed ID: 19027852
[TBL] [Abstract][Full Text] [Related]
57. Compression of pellets coated with various aqueous polymer dispersions.
Dashevsky A; Kolter K; Bodmeier R
Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
[TBL] [Abstract][Full Text] [Related]
58. Development and mathematical simulation of theophylline pulsatile release tablets.
Zhu Y; Zheng L
Drug Dev Ind Pharm; 2005 Dec; 31(10):1009-17. PubMed ID: 16316857
[TBL] [Abstract][Full Text] [Related]
59. Peculiar effect of polyethylene glycol in comparison with triethyl citrate or diethyl phthalate on properties of ethyl cellulose microcapsules containing propranolol hydrochloride in process of emulsion-solvent evaporation.
Afrasiabi Garekani H; Sanadgol N; Dehghan Nayyeri N; Nokhodchi A; Sadeghi F
Drug Dev Ind Pharm; 2018 Mar; 44(3):421-431. PubMed ID: 29098888
[TBL] [Abstract][Full Text] [Related]
60. A novel approach for dry powder coating of pellets with Ethylcellulose. Part I: Evaluation of film formulation and process set up.
Albertini B; Bertoni S; Melegari C; Dolci LS; Passerini N
Int J Pharm; 2017 Jan; 516(1-2):380-391. PubMed ID: 27894987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
